Pacific Biosciences of California, Inc. is a life science technology company. It is engaged in designing, developing, and manufacturing advanced sequencing solutions that enable scientists and clinical researchers to resolve genetically complex problems. Its products and technology under development stem from two differentiated core technologies, which include its HiFi long-read sequencing technology and its Sequencing by Binding (SBB) short-read sequencing technology. Its products address solutions across a set of applications, including human genetics, plant and animal sciences, infectious disease and microbiology, oncology, and other emerging applications. It has developed HiFi long-read sequencing based on Single-Molecule Real-Time technology, which accurately detects the nucleotide sequence and epigenetic status of individual DNA molecules. Its Revio, Sequel, Sequel II and Sequel IIe instruments conduct, monitor, and analyze single-molecule biochemical reactions in real time.
Símbolo de cotizaciónPACB
Nombre de la empresaPacific Biosciences of California Inc
Fecha de salida a bolsaOct 27, 2010
Director ejecutivoMr. Christian O. Henry
Número de empleados575
Tipo de seguridadOrdinary Share
Fin del año fiscalOct 27
Dirección1305 O'brien Drive
CiudadMENLO PARK
Bolsa de valoresNASDAQ Global Select Consolidated
PaísUnited States of America
Código postal94025
Teléfono16505218000
Sitio Webhttps://www.pacb.com/
Símbolo de cotizaciónPACB
Fecha de salida a bolsaOct 27, 2010
Director ejecutivoMr. Christian O. Henry
Un total de
0.00
USD se ha distribuido en dividendos durante los últimos 5 años.

Sin datos